News | August 02, 2024
Aster DM Healthcare posts Q1 FY25 PAT at Rs. 74 Cr
Q1 FY25 revenues up 20% YoY to Rs. 1,002 crore
Q1 FY25 revenues up 20% YoY to Rs. 1,002 crore
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
Aster Whitefield will be Aster's 3 rd multi-specialty hospital in Bengaluru and overall 19th hospital in India
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
Subscribe To Our Newsletter & Stay Updated
